Gene · 3460
Papers2,320
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,320
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Placental inflammatory cytokines mRNA expression and preschool children's cognitive performance: a birth cohort study in China. | BMC Med | 2023 | 37981714 | PubTator, text mining | PubMed |
| New insights into the genetic predisposition of brucellosis and its effect on the gut and vaginal microbiota in goats. | Sci Rep | 2023 | 37973848 | PubTator, text mining | PubMed |
| Investigating the Effect of Adherence to Antipsychotic Therapy on the Length of Stay and Number of Hospitalizations in Patients with Schizophrenia - A Descriptive Analysis. | Patient Prefer Adherence | 2023 | 37936717 | PubTator, text mining | PubMed |
| Colonic mucosal associated invariant T cells in Crohn's disease have a diverse and non-public T cell receptor beta chain repertoire. | PLoS One | 2023 | 37922286 | PubTator, text mining | PubMed |
| A comprehensive prognostic score for head and neck squamous cancer driver genes and phenotype traits. | Discov Oncol | 2023 | 37897503 | PubTator, text mining | PubMed |
| Design, synthesis and anticancer evaluation of polymethoxy aurones as potential cell cycle inhibitors. | Heliyon | 2023 | 37886750 | PubTator, text mining | PubMed |
| "Input/output cytokines" in epidermal keratinocytes and the involvement in inflammatory skin diseases. | Front Immunol | 2023 | 37881433 | PubTator, text mining | PubMed |
| Advancements in CRISPR screens for the development of cancer immunotherapy strategies. | Mol Ther Oncolytics | 2023 | 37876793 | PubTator, text mining | PubMed |
| Prognostic risk of immune-associated signature in the microenvironment of brain gliomas. | Front Genet | 2023 | 37867596 | PubTator, text mining | PubMed |
| The role of the interferon/JAK-STAT axis in driving islet HLA-I hyperexpression in type 1 diabetes. | Front Endocrinol (Lausanne) | 2023 | 37867531 | PubTator, text mining | PubMed |
| Cellular Heterogeneity of Activated Primary Human Macrophages and Associated Drug-Gene Networks: From Biology to Precision Therapeutics. | Circulation | 2023 | 37850387 | PubTator, text mining | PubMed |
| The Involvement of Neuroinflammation in the Onset and Progression of Parkinson's Disease. | Int J Mol Sci | 2023 | 37834030 | PubTator, text mining | PubMed |
| Overexpression of FRA1 (FOSL1) Leads to Global Transcriptional Perturbations, Reduced Cellular Adhesion and Altered Cell Cycle Progression. | Cells | 2023 | 37830558 | PubTator, text mining | PubMed |
| PLEKHA4 is a novel prognostic biomarker that reshapes the tumor microenvironment in lower-grade glioma. | Front Immunol | 2023 | 37818357 | PubTator, text mining | PubMed |
| Phenotype and fate of liver-resident CD8 T cells during acute and chronic hepacivirus infection. | PLoS Pathog | 2023 | 37812637 | PubTator, text mining | PubMed |
| Novel immune checkpoint-related gene model to predict prognosis and treatment responsiveness in low-grade gliomas. | Heliyon | 2023 | 37809899 | PubTator, text mining | PubMed |
| Optimization of small molecule degraders and antagonists for targeting estrogen receptor based on breast cancer: current status and future. | Front Pharmacol | 2023 | 37808197 | PubTator, text mining | PubMed |
| ERK mediates interferon gamma-induced melanoma cell death. | Mol Cancer | 2023 | 37803324 | PubTator, text mining | PubMed |
| The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity. | Nature | 2023 | 37794185 | PubTator, text mining | PubMed |
| Evaluating the prevalence of inborn errors of immunity in adults with chronic immune thrombocytopenia or Evans syndrome. | Blood Adv | 2023 | 37792884 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3460/papers?page=6